Investor relations

press releases

01/07/2021

PainReform to Present at the H.C. Wainwright Bioconnect 2021 Conference

01/06/2021

PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110

01/04/2021

PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations

12/03/2020

PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer

11/05/2020

PainReform Welcomes Senior Pharmaceutical Executive and Venture Capitalist Augustine Lawlor to Board of Directors

10/19/2020

PainReform Highlights Surgical Advantages of PRF-110